Liver Cancer | sciencenewsnet.in

Cedars-Sinai to Study How Fat May Promote Cancer Spread to Liver

February 6, 2020 sarah Jonas Liver Cancer, liver metastasis, Pancreatic Cancer

A diagnosis of pancreatic or colon cancer often sparks dread about the disease’s likely next destination: the liver. That’s because liver metastasis is a leading cause of death in these patients. A Cedars-Sinai scientific team has been awarded a $9.1 million grant by the National Cancer Institute to study this often-fatal process, with the goal of understanding how cancer spreads to the liver and finding ways to block it.

Research Results

New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet

January 20, 2020 sarah Jonas 0 Comments Liver Cancer, Nash

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance.

Research Results

Heterogeneity of Liver Cancer Cells Helps Explain Tumor Progression in Patients, Mount Sinai Research Found

January 15, 2020 sarah Jonas 0 Comments Clinical Trials, Immunotherapy, Liver Cancer, The Tisch Cancer Institute

Many liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect the rate at which the cancer grows, Mount Sinai researchers report. The immune system’s contribution to this heterogeneity can have major clinical implications.

Research Results

Math Equation Predicts and Detects Liver Cancer

December 16, 2019 sarah Jonas 0 Comments Bioinformatics, Cancer, Genetics, Hepatology, Liver Cancer

University of California San Diego School of Medicine and Moores Cancer Center researchers developed a math equation to predict and detect liver cancer and identified when healthy cells become cancerous.

Research Results

Natural Toxins in the Global Food Supply Continue to Threaten the Health of Underprivileged Communities

December 9, 2019 sarah Jonas 0 Comments Arsenic, cardiovascuar disease, Immune, lead, Liver Cancer, Neurological Disease, risk, Risk Analysis, Vaccine

Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health effects,, is also linked to vaccine resistance, and for the first time the global burden of disease from foodborne arsenic, lead, cadmium, and methyl mercury has been quantified.. The Society for Risk Analysis (SRA) will present new studies as part of its Global Disease Burden Caused by Foodborne Chemicals and Toxins symposium on Monday, Dec. 9 from 1:30-3:00 p.m. as part of its 2019 Annual Meeting at the Crystal Gateway Marriott in Arlington, Virginia. This symposium will provide updates to a 2015 World Health Organization (WHO) publication which analyzed the disease burdens caused by these toxins.

Research Results

New research suggests proton radiation therapy can benefit patients with challenging liver tumors

October 30, 2019 sarah Jonas 0 Comments American Society For Radiation Oncology, Liver Cancer, Proton Therapy, Radiation Therapy, Radiotherapy

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The studies were published in the International Journal of Radiation Oncology • Biology • Physics, the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).

Research Results

Study suggests new metabolic target for liver cancer

September 23, 2019 sarah Jonas 0 Comments Liver Cancer, Metabolism

Disrupting a metabolic pathway in the liver in a way that creates a more “cancer-like” metabolism actually reduces tumor formation in a mouse model of liver cancer. This surprising finding from a Univ. of Iowa study identifies the mitochondrial pyruvate carrier as a potential target for preventing liver cancer.